Sofia, Bulgaria, April 22, 2025 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for March 2025 the Company recorded increase in sales of 78% compared to the same month of the previous year, incl. 21% increase in domestic sales and 116% increase in export sales.

For the period from the beginning of 2025, the Company realized a 17% increase in sales, including 2% decrease in domestic sales and a 30% increase in export sales.

Sofia, Bulgaria, March 20, 2025 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for February 2025 the Company recorded a decrease in sales of 35% compared to the same month of the previous year, incl. 28% decrease in domestic sales and 42% decrease in export sales due to upcoming campaigns and logistical reasons respectively.